ArticlePerspectives on behavior science2023
Dissemination of Contingency Management for the Treatment of Opioid Use Disorder.
Article in Perspectives on behavior science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.
- The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder.Journal of addiction medicineGuideline
- Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): results of a 28-site cluster-randomized type 3 hybrid trial.Implementation science : IS · 2025Trial
- Cocaine abstinence during the "critical period" of a contingency management trial predicts future abstinence in people with cocaine use disorder.Drug and alcohol dependence · 2023Trial
- Tracking implementation determinants over time using the IFASIS: multi-site analysis of opioid treatment programs implementing a digital contingency management platform.Implementation science communications · 2025Article
- Digital Contingency Management for Substance Use Disorder Treatment: 12-Month Quasi-Experimental Design.JMIR mental health · 2025Article
- Introduction to the Special Issue on Public Policy Advocacy in Behavior Analysis: Chronicles from Behavior Analysts to Guide Future Public Policy Advocacy Action.Behavior analysis in practice · 2025Article
- Using the IFASIS (Inventory of Factors Affecting Successful Implementation and Sustainment) to advance context-specific and generalizable knowledge of implementation determinants: case study of a digital contingency management platform.Implementation science communications · 2025Article
- Adapting a Functional Assessment of Cigarette Smoking for People with Intellectual and Developmental Disabilities.Behavior analysis in practice · 2025Article
- Article
- Evolution of the substance use landscape: Implications for contingency management.Journal of applied behavior analysis · 2025Review
- War on Drugs in the Philippines: Evaluating Fear Appeals as Antidote to Continued Drug Use.Acta medica Philippina · 2025Article
- Article
- Introduction to the special series: using evidence to enhance health services for individuals using drugs in rural communities.Addiction science & clinical practice · 2024Article
- Feasibility, Acceptability, and Preliminary Efficacy of a Smartphone-Based Contingency Management Intervention for Buprenorphine Adherence.Behavior analysis in practice · 2023Article
- Implications of epidemic-pandemic convergence for routine care adoption of contingency management: A case study.Experimental and clinical psychopharmacology · 2023Article
- A Systematic Review of Treatment Maintenance Strategies in Token Economies: Implications for Contingency Management.Perspectives on behavior science · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Contingency management is an intervention for substance use disorders based on operant principles. The evidence base in support of contingency management is massive. It is effective in treating substance use disorder in general and opioid use disorder in particular. Dissemination has remained slow despite the urgency created by the opioid epidemic. Key barriers include a lack of expertise, time, and money. Implementing contingency management with smartphones eliminates the need for special training. It also solves logistical issues and requires little time on the part of clinicians. Thus, remaining barriers relate to cost. Federal anti-kickback regulations complicate solutions to the cost barrier. Other important regulatory challenges related to cost include the lack of billing codes and the difficulty of obtaining FDA approval for digital therapeutics. Even after the cost barrier is overcome, provider adoption is not guaranteed. Incentivizing providers for collaborative care may increase adoption and generate referrals. Recently proposed legislation and governmental policy statements provide optimism regarding the near-term large-scale adoption of contingency management in the treatment of opioid use disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.